{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T18:29:11Z","timestamp":1769192951478,"version":"3.49.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2011,11,1]],"date-time":"2011-11-01T00:00:00Z","timestamp":1320105600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,7]],"date-time":"2016-10-07T00:00:00Z","timestamp":1475798400000},"content-version":"vor","delay-in-days":1802,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2011,11]]},"DOI":"10.1038\/mt.2011.162","type":"journal-article","created":{"date-parts":[[2011,8,16]],"date-time":"2011-08-16T10:25:48Z","timestamp":1313490348000},"page":"2072-2083","source":"Crossref","is-referenced-by-count":31,"title":["Erythropoietin Gene-enhanced Marrow Mesenchymal Stromal Cells Decrease Cisplatin-induced Kidney Injury and Improve Survival of Allogeneic Mice"],"prefix":"10.1016","volume":"19","author":[{"given":"Nicoletta","family":"Eliopoulos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kathy","family":"Forner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Birman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoon Kow","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manaf","family":"Bouchentouf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1038\/mt.2011.162_bib1","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.semcdb.2007.09.012","article-title":"Therapeutic applications of mesenchymal stromal cells","volume":"18","author":"Brooke","year":"2007","journal-title":"Semin Cell Dev Biol"},{"key":"10.1038\/mt.2011.162_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1038\/mt.2009.62","article-title":"Repair of tissues by adult stem\/progenitor cells (MSCs): controversies, myths, and changing paradigms","volume":"17","author":"Prockop","year":"2009","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.162_bib3","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1016\/j.molmed.2008.05.005","article-title":"Stem-cell approaches for kidney repair: choosing the right cells","volume":"14","author":"Sagrinati","year":"2008","journal-title":"Trends Mol Med"},{"key":"10.1038\/mt.2011.162_bib4","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/nri2395","article-title":"Mesenchymal stem cells in health and disease","volume":"8","author":"Uccelli","year":"2008","journal-title":"Nat Rev Immunol"},{"key":"10.1038\/mt.2011.162_bib5","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1681\/ASN.2007020140","article-title":"Stromal cells protect against acute tubular injury via an endocrine effect","volume":"18","author":"Bi","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2011.162_bib6","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.surg.2007.10.015","article-title":"Surgically relevant aspects of stem cell paracrine effects","volume":"143","author":"Crisostomo","year":"2008","journal-title":"Surgery"},{"key":"10.1038\/mt.2011.162_bib7","doi-asserted-by":"crossref","first-page":"2921","DOI":"10.1681\/ASN.2006121318","article-title":"Insulin-like growth factor-1 sustains stem cell mediated renal repair","volume":"18","author":"Imberti","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2011.162_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1172\/JCI17856","article-title":"Bone marrow stem cells contribute to repair of the ischemically injured renal tubule","volume":"112","author":"Kale","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1038\/mt.2011.162_bib9","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"key":"10.1038\/mt.2011.162_bib10","doi-asserted-by":"crossref","first-page":"F31","DOI":"10.1152\/ajprenal.00007.2005","article-title":"Administered mesenchymal stem cells protect against ischemic acute renal failure through differentiation-independent mechanisms","volume":"289","author":"T\u00f6gel","year":"2005","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/mt.2011.162_bib11","doi-asserted-by":"crossref","first-page":"F1626","DOI":"10.1152\/ajprenal.00339.2006","article-title":"Vasculotropic, paracrine actions of infused mesenchymal stem cells are important to the recovery from acute kidney injury","volume":"292","author":"T\u00f6gel","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/mt.2011.162_bib12","first-page":"1035","article-title":"Mesenchymal stem cells contribute to the renal repair of acute tubular epithelial injury","volume":"14","author":"Herrera","year":"2004","journal-title":"Int J Mol Med"},{"key":"10.1038\/mt.2011.162_bib13","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1097\/01.ASN.0000128974.07460.34","article-title":"Mesenchymal stem cells are renotropic, helping to repair the kidney and improve function in acute renal failure","volume":"15","author":"Morigi","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2011.162_bib14","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1001\/jama.293.1.90","article-title":"New avenues of exploration for erythropoietin","volume":"293","author":"Maiese","year":"2005","journal-title":"JAMA"},{"key":"10.1038\/mt.2011.162_bib15","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1634\/theoncologist.8-suppl_3-18","article-title":"New insights into erythropoietin and epoetin alfa: mechanisms of action, target tissues, and clinical applications","volume":"8 Suppl 3","author":"Weiss","year":"2003","journal-title":"Oncologist"},{"key":"10.1038\/mt.2011.162_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1159\/000065304","article-title":"Unexpected renal actions of erythropoietin","volume":"10","author":"Westenfelder","year":"2002","journal-title":"Exp Nephrol"},{"key":"10.1038\/mt.2011.162_bib17","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1093\/ndt\/16.5.932","article-title":"Erythropoietin enhances recovery after cisplatin-induced acute renal failure in the rat","volume":"16","author":"Bagnis","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mt.2011.162_bib18","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MNH.0b013e32831a9dde","article-title":"Erythropoietin and renoprotection","volume":"18","author":"Bahlmann","year":"2009","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1038\/mt.2011.162_bib19","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1053\/j.seminhematol.2007.04.008","article-title":"Erythropoietin and treatment of non-anemic conditions\u2013cardiovascular protection","volume":"44","author":"Fliser","year":"2007","journal-title":"Semin Hematol"},{"key":"10.1038\/mt.2011.162_bib20","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1038\/sj.ki.5000356","article-title":"Delayed administration of darbepoetin or erythropoietin protects against ischemic acute renal injury and failure","volume":"69","author":"Johnson","year":"2006","journal-title":"Kidney Int"},{"issue":"3 Pt 2","key":"10.1038\/mt.2011.162_bib21","first-page":"F360","article-title":"Erythropoietin enhances recovery from cisplatin-induced acute renal failure","volume":"266","author":"Vaziri","year":"1994","journal-title":"Am J Physiol"},{"key":"10.1038\/mt.2011.162_bib22","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1089\/10430340152480258","article-title":"Baboon mesenchymal stem cells can be genetically modified to secrete human erythropoietin in vivo","volume":"12","author":"Bartholomew","year":"2001","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.162_bib23","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1038\/sj.gt.3301727","article-title":"Enhanced engraftment of EPO-transduced human bone marrow stromal cells transplanted in a 3D matrix in non-conditioned NOD\/SCID mice","volume":"9","author":"Daga","year":"2002","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.162_bib24","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1038\/sj.gt.3301919","article-title":"A neovascularized organoid derived from retrovirally engineered bone marrow stroma leads to prolonged in vivo systemic delivery of erythropoietin in nonmyeloablated, immunocompetent mice","volume":"10","author":"Eliopoulos","year":"2003","journal-title":"Gene Ther"},{"key":"10.1038\/mt.2011.162_bib25","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1681\/ASN.2005101035","article-title":"Erythropoietin delivery by genetically engineered bone marrow stromal cells for correction of anemia in mice with chronic renal failure","volume":"17","author":"Eliopoulos","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2011.162_bib26","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.ymthe.2004.07.004","article-title":"Human-compatible collagen matrix for prolonged and reversible systemic delivery of erythropoietin in mice from gene-modified marrow stromal cells","volume":"10","author":"Eliopoulos","year":"2004","journal-title":"Mol Ther"},{"key":"10.1038\/mt.2011.162_bib27","first-page":"1209","article-title":"The application of stem cells in the treatment of ischemic diseases","volume":"21","author":"Chen","year":"2006","journal-title":"Histol Histopathol"},{"key":"10.1038\/mt.2011.162_bib28","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5002334","article-title":"Exogenous mesenchymal stem cells localize to the kidney by means of CD44 following acute tubular injury","volume":"72","author":"Herrera","year":"2007","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.162_bib29","doi-asserted-by":"crossref","first-page":"2","DOI":"10.2174\/157488809787169129","article-title":"Contribution of stem cells to kidney repair","volume":"4","author":"Bussolati","year":"2009","journal-title":"Curr Stem Cell Res Ther"},{"key":"10.1038\/mt.2011.162_bib30","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1093\/ndt\/gfg455","article-title":"Erythropoietin: is it more than correcting anaemia","volume":"19","author":"Bahlmann","year":"2004","journal-title":"Nephrol Dial Transplant"},{"key":"10.1038\/mt.2011.162_bib31","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/sj.ki.5002702","article-title":"The phosphoinositide-3 kinase gamma-Akt pathway mediates renal tubular injury in cisplatin nephrotoxicity","volume":"73","author":"Kuwana","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.162_bib32","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1089\/scd.2008.0092","article-title":"Autologous and allogeneic marrow stromal cells are safe and effective for the treatment of acute kidney injury","volume":"18","author":"T\u00f6gel","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1038\/mt.2011.162_bib33","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/j.1523-1755.2004.00400.x","article-title":"Cytoprotection by darbepoetin\/epoetin alfa in pig tubular and mouse mesangial cells","volume":"65","author":"Fishbane","year":"2004","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.162_bib34","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1097\/01.ASN.0000135059.67385.5D","article-title":"Erythropoietin protects the kidney against the injury and dysfunction caused by ischemia-reperfusion","volume":"15","author":"Sharples","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1038\/mt.2011.162_bib35","doi-asserted-by":"crossref","first-page":"4057","DOI":"10.1182\/blood-2005-03-1004","article-title":"Allogeneic marrow stromal cells are immune rejected by MHC class I- and class II-mismatched recipient mice","volume":"106","author":"Eliopoulos","year":"2005","journal-title":"Blood"},{"key":"10.1038\/mt.2011.162_bib36","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S0270-9295(03)00089-5","article-title":"Cisplatin nephrotoxicity","volume":"23","author":"Arany","year":"2003","journal-title":"Semin Nephrol"},{"key":"10.1038\/mt.2011.162_bib37","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1038\/sj.ki.5002786","article-title":"Cisplatin nephrotoxicity: mechanisms and renoprotective strategies","volume":"73","author":"Pabla","year":"2008","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.162_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/(SICI)1520-670X(1998)11:1<37::AID-JTRA5>3.0.CO;2-0","article-title":"Distribution of platinum in patients treated with cisplatin determined by radiochemical neutron activation analysis","volume":"11","author":"Heydorn","year":"1998","journal-title":"J Trace Elem Exp Med"},{"key":"10.1038\/mt.2011.162_bib39","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1053\/j.gastro.2008.03.015","article-title":"Stem cell therapy for liver disease: parameters governing the success of using bone marrow mesenchymal stem cells","volume":"134","author":"Kuo","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1038\/mt.2011.162_bib40","doi-asserted-by":"crossref","first-page":"17438","DOI":"10.1073\/pnas.0608249103","article-title":"Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice","volume":"103","author":"Lee","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/mt.2011.162_bib41","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1136\/pgmj.2005.038588","article-title":"Management of acute renal failure","volume":"82","author":"Fry","year":"2006","journal-title":"Postgrad Med J"},{"key":"10.1038\/mt.2011.162_bib42","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ki.2008.683","article-title":"Ischemic and non-ischemic acute kidney injury cause hepatic damage","volume":"75","author":"Golab","year":"2009","journal-title":"Kidney Int"},{"key":"10.1038\/mt.2011.162_bib43","doi-asserted-by":"crossref","first-page":"F30","DOI":"10.1152\/ajprenal.00023.2007","article-title":"Ischemic acute kidney injury induces a distant organ functional and genomic response distinguishable from bilateral nephrectomy","volume":"293","author":"Hassoun","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1038\/mt.2011.162_bib44","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.semnephrol.2005.09.003","article-title":"Acute renal failure: much more than a kidney disease","volume":"26","author":"Kelly","year":"2006","journal-title":"Semin Nephrol"},{"key":"10.1038\/mt.2011.162_bib45","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/hum.2008.016","article-title":"Kallikrein-modified mesenchymal stem cell implantation provides enhanced protection against acute ischemic kidney injury by inhibiting apoptosis and inflammation","volume":"19","author":"Hagiwara","year":"2008","journal-title":"Hum Gene Ther"},{"key":"10.1038\/mt.2011.162_bib46","first-page":"31","article-title":"Initial report on a phase I clinical trial: Prevention and treatment of post-operative acute kidney injury with allogeneic mesenchymal stem cells in patients who require on-pump cardiac surgery","volume":"1","author":"Gooch","year":"2008","journal-title":"Cell Ther Transplant"},{"key":"10.1038\/mt.2011.162_bib47","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1046\/j.1365-2141.2003.04669.x","article-title":"Murine marrow-derived mesenchymal stem cell: isolation, in vitro expansion, and characterization","volume":"123","author":"Meirelles","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1038\/mt.2011.162_bib48","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1002\/(SICI)1097-4644(19990315)72:4<570::AID-JCB12>3.0.CO;2-W","article-title":"Plastic adherent stromal cells from the bone marrow of commonly used strains of inbred mice: variations in yield, growth, and differentiation","volume":"72","author":"Phinney","year":"1999","journal-title":"J Cell Biochem"}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616328052?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525001616328052?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,11,30]],"date-time":"2018-11-30T13:51:44Z","timestamp":1543585904000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525001616328052"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,11]]},"references-count":48,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2011,11]]}},"alternative-id":["S1525001616328052"],"URL":"https:\/\/doi.org\/10.1038\/mt.2011.162","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2011,11]]}}}